Keywords
Last Name
Institution

Erin A. McClure

Title
InstitutionMedical University of South Carolina
DepartmentPsychiatry and Behavioral Sciences
AddressP.O. Box MSC 861
67 President St.
Phone843-792-7192
Email
vCardDownload vCard

    Collapse Overview 
    Collapse studies/trials
    Collapse overview
    Dr. McClure’s research interests and activities involve the study of relapse, withdrawal, craving, and treatment for nicotine and cannabis dependence through the use of outpatient, laboratory-based studies, as well as clinical trials assessing pharmacological and behavioral interventions in both adolescents and adults. Dr. McClure is also interested in the utilization of different technology outlets to conduct fine-grained analyses of the process of relapse to inform treatment efforts and deliver interventions in real-time.
    Collapse keywords
    smoking cessation, nicotine dependence, mobile health, relapse, pharmacotherapy, smoking, adolescent

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. McClure EA. Accurate and sufficient measurement of cannabis and tobacco co-use: agreement, consensus and the path forward. Addiction. 2021 Jul; 116(7):1636-1637. PMID: 33855758.
      View in: PubMed
    2. Tuck BM, Karelitz JL, Tomko RL, Dahne J, Cato P, McClure EA. Mobile, Remote, and Individual Focused: Comparing Breath Carbon Monoxide Readings and Abstinence Between Smartphone-Enabled and Stand-Alone Monitors. Nicotine Tob Res. 2021 03 19; 23(4):741-747. PMID: 33022057.
      View in: PubMed
    3. Karelitz JL, McClure EA, Wolford-Clevenger C, Pacek LR, Cropsey KL. Cessation classification likelihood increases with higher expired-air carbon monoxide cutoffs: a meta-analysis. Drug Alcohol Depend. 2021 04 01; 221:108570. PMID: 33592559.
      View in: PubMed
    4. Dahne J, Tomko RL, McClure EA, Obeid JS, Carpenter MJ. Remote Methods for Conducting Tobacco-Focused Clinical Trials. Nicotine Tob Res. 2020 12 12; 22(12):2134-2140. PMID: 32531046.
      View in: PubMed
    5. Hindocha C, McClure EA. Unknown population-level harms of cannabis and tobacco co-use: if you don't measure it, you can't manage it. Addiction. 2021 Jul; 116(7):1622-1630. PMID: 33047862.
      View in: PubMed
    6. McClure EA, Rabin RA, Lee DC, Hindocha C. Treatment Implications Associated with Cannabis and Tobacco Co-Use. Curr Addict Rep. 2020 Dec; 7(4):533-544. PMID: 33777645.
      View in: PubMed
    7. McClure EA, Baker NL, Hood CO, Tomko RL, Squeglia LM, Flanagan JC, Carpenter MJ, Gray KM. Cannabis and Alcohol Co-Use in a Smoking Cessation Pharmacotherapy Trial for Adolescents and Emerging Adults. Nicotine Tob Res. 2020 07 16; 22(8):1374-1382. PMID: 31612956.
      View in: PubMed
    8. Hood CO, Tomko RL, Baker NL, Tuck BM, Flanagan JC, Carpenter MJ, Gray KM, Saladin ME, McClure EA. Examining sex, adverse childhood experiences, and oxytocin on neuroendocrine reactivity in smokers. Psychoneuroendocrinology. 2020 10; 120:104752. PMID: 32634745.
      View in: PubMed
    9. Baker NL, Gray KM, Ramakrishnan V, Tomko RL, McClure EA, Carpenter MJ, Saladin ME. Increases in endogenous progesterone attenuate smoking in a cohort of nontreatment seeking women: An exploratory prospective study. Addict Biol. 2021 03; 26(2):e12918. PMID: 32476209.
      View in: PubMed
    10. McClure EA, Carpenter MJ. Commentary on Guillaumier et al. (2020): Is harm reduction a suitable outcome for historically hard-to-treat smokers? Addiction. 2020 07; 115(7):1356-1357. PMID: 32293762.
      View in: PubMed
    11. Flanagan JC, Leone RM, Gilmore AK, McClure EA, Gray KM. Association of Cannabis Use With Intimate Partner Violence Among Couples With Substance Misuse. Am J Addict. 2020 07; 29(4):323-330. PMID: 32219903.
      View in: PubMed
    12. Carpenter RW, Squeglia LM, Emery NN, McClure EA, Gray KM, Miranda R, Tomko RL. Making pharmacotherapy trials for substance use disorder more efficient: Leveraging real-world data capture to maximize power and expedite the medication development pipeline. Drug Alcohol Depend. 2020 04 01; 209:107897. PMID: 32058245.
      View in: PubMed
    13. Tomko RL, Saladin ME, Baker NL, McClure EA, Carpenter MJ, Ramakrishnan VR, Heckman BW, Wray JM, Foster KT, Tiffany ST, Metts CL, Gray KM. Sex Differences in Subjective and Behavioral Responses to Stressful and Smoking Cues Presented in the Natural Environment of Smokers. Nicotine Tob Res. 2020 01 27; 22(1):81-88. PMID: 30371887.
      View in: PubMed
    14. McClure EA, Baker NL, Gray KM, Hood CO, Tomko RL, Carpenter MJ, Ramakrishnan VR, Buchanan CJ, Saladin ME. The influence of gender and oxytocin on stress reactivity, cigarette craving, and smoking in a randomized, placebo-controlled laboratory relapse paradigm. Psychopharmacology (Berl). 2020 Feb; 237(2):543-555. PMID: 31792646.
      View in: PubMed
    15. Gray KM, Baker NL, McClure EA, Tomko RL, Squeglia LM, Saladin ME, Carpenter MJ. Efficacy and Safety of Varenicline for Adolescent Smoking Cessation: A Randomized Clinical Trial. JAMA Pediatr. 2019 Dec 01; 173(12):1146-1153. PMID: 31609433.
      View in: PubMed
    16. Tomko RL, Gray KM, Huestis MA, Squeglia LM, Baker NL, McClure EA. Measuring Within-Individual Cannabis Reduction in Clinical Trials: A Review of the Methodological Challenges. Curr Addict Rep. 2019 Dec; 6(4):429-436. PMID: 32133273.
      View in: PubMed
    17. Tomko RL, Baker NL, Hood CO, Gilmore AK, McClure EA, Squeglia LM, McRae-Clark AL, Sonne SC, Gray KM. Depressive symptoms and cannabis use in a placebo-controlled trial of N-Acetylcysteine for adult cannabis use disorder. Psychopharmacology (Berl). 2020 Feb; 237(2):479-490. PMID: 31712969.
      View in: PubMed
    18. Tomko RL, McClure EA, Cato PA, Wang JB, Carpenter MJ, Karelitz JL, Froeliger B, Saladin ME, Gray KM. An electronic, smart lighter to measure cigarette smoking: A pilot study to assess feasibility and initial validity. Addict Behav. 2019 11; 98:106052. PMID: 31415971.
      View in: PubMed
    19. Squeglia LM, Fadus MC, McClure EA, Tomko RL, Gray KM. Pharmacological Treatment of Youth Substance Use Disorders. J Child Adolesc Psychopharmacol. 2019 08; 29(7):559-572. PMID: 31009234.
      View in: PubMed
    20. Montgomery L, McClure EA, Tomko RL, Sonne SC, Winhusen T, Terry GE, Grossman JT, Gray KM. Blunts versus joints: Cannabis use characteristics and consequences among treatment-seeking adults. Drug Alcohol Depend. 2019 05 01; 198:105-111. PMID: 30901744.
      View in: PubMed
    21. Salazar CA, Tomko RL, Akbar SA, Squeglia LM, McClure EA. Medical Cannabis Use among Adults in the Southeastern United States. Cannabis. 2019 Feb 09; 2(1):53-65. PMID: 30815638.
      View in: PubMed
    22. Goenaga J, Powell GL, Leyrer-Jackson JM, Piña J, Phan S, Prakapenka AV, Koebele SV, Namba MD, McClure EA, Bimonte-Nelson HA, Gipson CD. N-acetylcysteine yields sex-specific efficacy for cue-induced reinstatement of nicotine seeking. Addict Biol. 2020 01; 25(1):e12711. PMID: 30734439.
      View in: PubMed
    23. Tomko RL, McClure EA, Squeglia LM, Treloar Padovano H, McRae-Clark AL, Baker NL, Carpenter MJ, Gray KM. Methods to reduce the incidence of false negative trial results in substance use treatment research. Curr Opin Psychol. 2019 12; 30:35-41. PMID: 30798020.
      View in: PubMed
    24. Powell GL, Leyrer-Jackson JM, Goenaga J, Namba MD, Piña J, Spencer S, Stankeviciute N, Schwartz D, Allen NP, Del Franco AP, McClure EA, Olive MF, Gipson CD. Chronic treatment with N-acetylcysteine decreases extinction responding and reduces cue-induced nicotine-seeking. Physiol Rep. 2019 01; 7(1):e13958. PMID: 30632301.
      View in: PubMed
    25. McClure EA, Tomko RL, Salazar CA, Akbar SA, Squeglia LM, Herrmann E, Carpenter MJ, Peters EN. Tobacco and cannabis co-use: Drug substitution, quit interest, and cessation preferences. Exp Clin Psychopharmacol. 2019 Jun; 27(3):265-275. PMID: 30556733.
      View in: PubMed
    26. Akbar SA, Tomko RL, Salazar CA, Squeglia LM, McClure EA. Tobacco and cannabis co-use and interrelatedness among adults. Addict Behav. 2019 03; 90:354-361. PMID: 30522075.
      View in: PubMed
    27. Nowling TK, McClure E, Simpson A, Sheidow AJ, Shaw D, Feghali-Bostwick C. A Focused Career Development Program for Women Faculty at an Academic Medical Center. J Womens Health (Larchmt). 2018 12; 27(12):1474-1481. PMID: 30251910.
      View in: PubMed
    28. McClure EA, Baker NL, Sonne SC, Ghitza UE, Tomko RL, Montgomery L, Babalonis S, Terry GE, Gray KM. Tobacco use during cannabis cessation: Use patterns and impact on abstinence in a National Drug Abuse Treatment Clinical Trials Network study. Drug Alcohol Depend. 2018 11 01; 192:59-66. PMID: 30218864.
      View in: PubMed
    29. McClure EA, Tomko RL, Carpenter MJ, Treiber FA, Gray KM. Acceptability and compliance with a remote monitoring system to track smoking and abstinence among young smokers. Am J Drug Alcohol Abuse. 2018; 44(5):561-570. PMID: 29737885.
      View in: PubMed
    30. Acquavita SP, Krummel DA, Talks A, Cobb A, McClure E. Assessing the Digital Divide Among Low-Income Perinatal Women: Opportunities for Provision of Health Information and Counseling. Telemed J E Health. 2019 01; 25(1):48-54. PMID: 29708865.
      View in: PubMed
    31. Tomko RL, McClure EA. Introduction to the special issue: Utilizing ambulatory assessment to better understand the etiology, maintenance, treatment, and remission of addictive disorders. Addict Behav. 2018 08; 83:1-4. PMID: 29661656.
      View in: PubMed
    32. Tomko RL, Gray KM, Oppenheimer SR, Wahlquist AE, McClure EA. Using REDCap for ambulatory assessment: Implementation in a clinical trial for smoking cessation to augment in-person data collection. Am J Drug Alcohol Abuse. 2019; 45(1):26-41. PMID: 29513609.
      View in: PubMed
    33. Squeglia LM, Tomko RL, Baker NL, McClure EA, Book GA, Gray KM. The effect of N-acetylcysteine on alcohol use during a cannabis cessation trial. Drug Alcohol Depend. 2018 04 01; 185:17-22. PMID: 29413434.
      View in: PubMed
    34. Tomko RL, Baker NL, McClure EA, Sonne SC, McRae-Clark AL, Sherman BJ, Gray KM. Incremental validity of estimated cannabis grams as a predictor of problems and cannabinoid biomarkers: Evidence from a clinical trial. Drug Alcohol Depend. 2018 01 01; 182:1-7. PMID: 29112827.
      View in: PubMed
    35. Buchanan C, Nahhas GJ, Guille C, Cummings KM, Wheeler C, McClure EA. Tobacco Use Prevalence and Outcomes Among Perinatal Patients Assessed Through an "Opt-out" Cessation and Follow-Up Clinical Program. Matern Child Health J. 2017 Sep; 21(9):1790-1797. PMID: 28702864.
      View in: PubMed
    36. Hser YI, Mooney LJ, Huang D, Zhu Y, Tomko RL, McClure E, Chou CP, Gray KM. Reductions in cannabis use are associated with improvements in anxiety, depression, and sleep quality, but not quality of life. J Subst Abuse Treat. 2017 10; 81:53-58. PMID: 28847455.
      View in: PubMed
    37. Gray KM, Sonne SC, McClure EA, Ghitza UE, Matthews AG, McRae-Clark AL, Carroll KM, Potter JS, Wiest K, Mooney LJ, Hasson A, Walsh SL, Lofwall MR, Babalonis S, Lindblad RW, Sparenborg S, Wahle A, King JS, Baker NL, Tomko RL, Haynes LF, Vandrey RG, Levin FR. A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults. Drug Alcohol Depend. 2017 08 01; 177:249-257. PMID: 28623823.
      View in: PubMed
    38. McClure EA, King JS, Wahle A, Matthews AG, Sonne SC, Lofwall MR, McRae-Clark AL, Ghitza UE, Martinez M, Cloud K, Virk HS, Gray KM. Comparing adult cannabis treatment-seekers enrolled in a clinical trial with national samples of cannabis users in the United States. Drug Alcohol Depend. 2017 07 01; 176:14-20. PMID: 28511033.
      View in: PubMed
    39. Tomko RL, Saladin ME, McClure EA, Squeglia LM, Carpenter MJ, Tiffany ST, Baker NL, Gray KM. Alcohol consumption as a predictor of reactivity to smoking and stress cues presented in the natural environment of smokers. Psychopharmacology (Berl). 2017 Feb; 234(3):427-435. PMID: 27838746.
      View in: PubMed
    40. W Adams Z, McClure EA, Gray KM, Danielson CK, Treiber FA, Ruggiero KJ. Mobile devices for the remote acquisition of physiological and behavioral biomarkers in psychiatric clinical research. J Psychiatr Res. 2017 02; 85:1-14. PMID: 27814455.
      View in: PubMed
    41. Lévesque A, Campbell AN, Pavlicova M, Hu MC, Walker R, McClure EA, Ghitza UE, Bailey G, Stitzer M, Nunes EV. Coping strategies as a mediator of internet-delivered psychosocial treatment: Secondary analysis from a NIDA CTN multisite effectiveness trial. Addict Behav. 2017 02; 65:74-80. PMID: 27776269.
      View in: PubMed
    42. Squeglia LM, Baker NL, McClure EA, Tomko RL, Adisetiyo V, Gray KM. Alcohol use during a trial of N-acetylcysteine for adolescent marijuana cessation. Addict Behav. 2016 12; 63:172-7. PMID: 27521979.
      View in: PubMed
    43. Flanagan JC, Hakes JK, McClure EA, Snead AL, Back SE. Effects of intimate partner violence, PTSD, and alcohol use on cigarette smoking in a nationally representative sample. Am J Addict. 2016 06; 25(4):283-90. PMID: 27196699.
      View in: PubMed
    44. Foster KT, Li N, McClure EA, Sonne SC, Gray KM. Gender Differences in Internalizing Symptoms and Suicide Risk Among Men and Women Seeking Treatment for Cannabis Use Disorder from Late Adolescence to Middle Adulthood. J Subst Abuse Treat. 2016 07; 66:16-22. PMID: 27211992.
      View in: PubMed
    45. McClure E, Baker N, Carpenter MJ, Treiber FA, Gray K. Attitudes and interest in technology-based treatment and the remote monitoring of smoking among adolescents and emerging adults. J Smok Cessat. 2017 Jun; 12(2):88-98. PMID: 28580019.
      View in: PubMed
    46. Froeliger B, McConnell PA, Stankeviciute N, McClure EA, Kalivas PW, Gray KM. The effects of N-Acetylcysteine on frontostriatal resting-state functional connectivity, withdrawal symptoms and smoking abstinence: A double-blind, placebo-controlled fMRI pilot study. Drug Alcohol Depend. 2015 Nov 01; 156:234-242. PMID: 26454838.
      View in: PubMed
    47. Wray JM, Gray KM, McClure EA, Carpenter MJ, Tiffany ST, Saladin ME. Gender differences in responses to cues presented in the natural environment of cigarette smokers. Nicotine Tob Res. 2015 Apr; 17(4):438-42. PMID: 25762753.
      View in: PubMed
    48. Saladin ME, McClure EA, Baker NL, Carpenter MJ, Ramakrishnan V, Hartwell KJ, Gray KM. Increasing progesterone levels are associated with smoking abstinence among free-cycling women smokers who receive brief pharmacotherapy. Nicotine Tob Res. 2015 Apr; 17(4):398-406. PMID: 25762749.
      View in: PubMed
    49. Gray KM, McClure EA, Baker NL, Hartwell KJ, Carpenter MJ, Saladin ME. An exploratory short-term double-blind randomized trial of varenicline versus nicotine patch for smoking cessation in women. Addiction. 2015 Jun; 110(6):1027-34. PMID: 25727442.
      View in: PubMed
    50. Mitchell SG, Schwartz RP, Alvanzo AA, Weisman MS, Kyle TL, Turrigiano EM, Gibson ML, Perez L, McClure EA, Clingerman S, Froias A, Shandera DR, Walker R, Babcock DL, Bailey GL, Miele GM, Kunkel LE, Norton M, Stitzer ML. The Use of Technology in Participant Tracking and Study Retention: Lessons Learned From a Clinical Trials Network Study. Subst Abus. 2015; 36(4):420-6. PMID: 25671593.
      View in: PubMed
    51. McClure EA, Lydiard JB, Goddard SD, Gray KM. Objective and subjective memory ratings in cannabis-dependent adolescents. Am J Addict. 2015 Jan; 24(1):47-52. PMID: 25823635.
      View in: PubMed
    52. McClure EA, Campbell AN, Pavlicova M, Hu M, Winhusen T, Vandrey RG, Ruglass LM, Covey LS, Stitzer ML, Kyle TL, Nunes EV. Cigarette Smoking During Substance Use Disorder Treatment: Secondary Outcomes from a National Drug Abuse Treatment Clinical Trials Network study. J Subst Abuse Treat. 2015 Jun; 53:39-46. PMID: 25595301.
      View in: PubMed
    53. McClure EA, Lydiard JB, Goddard SD, Gray KM. Objective and subjective memory ratings in cannabis-dependent adolescents. Am J Addict. 2014 Nov 6. PMID: 25376891.
      View in: PubMed
    54. Saladin ME, Wray JM, Carpenter MJ, McClure EA, LaRowe SD, Upadhyaya HP, Gray KM. Menstrual cycle phase effects in the gender dimorphic stress cue reactivity of smokers. Nicotine Tob Res. 2015 May; 17(5):607-11. PMID: 25324432.
      View in: PubMed
    55. McClure EA, Sonne SC, Winhusen T, Carroll KM, Ghitza UE, McRae-Clark AL, Matthews AG, Sharma G, Van Veldhuisen P, Vandrey RG, Levin FR, Weiss RD, Lindblad R, Allen C, Mooney LJ, Haynes L, Brigham GS, Sparenborg S, Hasson AL, Gray KM. Achieving cannabis cessation -- evaluating N-acetylcysteine treatment (ACCENT): design and implementation of a multi-site, randomized controlled study in the National Institute on Drug Abuse Clinical Trials Network. Contemp Clin Trials. 2014 Nov; 39(2):211-23. PMID: 25179587.
      View in: PubMed
    56. McClure EA, Baker NL, Gipson CD, Carpenter MJ, Roper AP, Froeliger BE, Kalivas PW, Gray KM. An open-label pilot trial of N-acetylcysteine and varenicline in adult cigarette smokers. Am J Drug Alcohol Abuse. 2015 Jan; 41(1):52-6. PMID: 25062287.
      View in: PubMed
    57. Acquavita SP, McClure EA, Hargraves D, Stitzer M. Environmental tobacco smoke exposure among smokers and non-smokers receiving outpatient substance abuse treatment. Addict Behav. 2014 Dec; 39(12):1718-22. PMID: 25117848.
      View in: PubMed
    58. Campbell AN, Nunes EV, Matthews AG, Stitzer M, Miele GM, Polsky D, Turrigiano E, Walters S, McClure EA, Kyle TL, Wahle A, Van Veldhuisen P, Goldman B, Babcock D, Stabile PQ, Winhusen T, Ghitza UE. Internet-delivered treatment for substance abuse: a multisite randomized controlled trial. Am J Psychiatry. 2014 Jun; 171(6):683-90. PMID: 24700332.
      View in: PubMed
    59. McClure EA, Baker NL, Gray KM. Cigarette smoking during an N-acetylcysteine-assisted cannabis cessation trial in adolescents. Am J Drug Alcohol Abuse. 2014 Jul; 40(4):285-91. PMID: 24720376.
      View in: PubMed
    60. Raiff BR, Karatas Ç, McClure EA, Pompili D, Walls TA. Laboratory Validation of Inertial Body Sensors to Detect Cigarette Smoking Arm Movements. Electronics (Basel). 2014 Feb 27; 3(1):87-110. PMID: 25553255.
      View in: PubMed
    61. McClure EA, Gipson CD, Malcolm RJ, Kalivas PW, Gray KM. Potential role of N-acetylcysteine in the management of substance use disorders. CNS Drugs. 2014 Feb; 28(2):95-106. PMID: 24442756.
      View in: PubMed
    62. Carpenter MJ, Saladin ME, Larowe SD, McClure EA, Simonian S, Upadhyaya HP, Gray KM. Craving, cue reactivity, and stimulus control among early-stage young smokers: effects of smoking intensity and gender. Nicotine Tob Res. 2014 Feb; 16(2):208-15. PMID: 24042699.
      View in: PubMed
    63. Campbell AN, Nunes EV, McClure EA, Hu MC, Turrigiano E, Goldman B, Stabile PQ. Characteristics of an outpatient treatment sample by primary substance of abuse. J Addict Med. 2013 Sep-Oct; 7(5):363-71. PMID: 24089040.
      View in: PubMed
    64. McClure EA, Acquavita SP, Dunn KE, Stoller KB, Stitzer ML. Characterizing smoking, cessation services, and quit interest across outpatient substance abuse treatment modalities. J Subst Abuse Treat. 2014 Feb; 46(2):194-201. PMID: 23988192.
      View in: PubMed
    65. McClure EA, Saladin ME, Baker NL, Carpenter MJ, Gray KM. Smoking topography and abstinence in adult female smokers. Addict Behav. 2013 Dec; 38(12):2833-6. PMID: 24018226.
      View in: PubMed
    66. McClure EA, Gray KM. The Remote Monitoring of Smoking in Adolescents. Adolesc Psychiatry (Hilversum). 2013 Apr 01; 3(2):156-162. PMID: 24834379.
      View in: PubMed
    67. McClure EA, Acquavita SP, Harding E, Stitzer ML. Utilization of communication technology by patients enrolled in substance abuse treatment. Drug Alcohol Depend. 2013 Apr 01; 129(1-2):145-50. PMID: 23107600.
      View in: PubMed
    68. McClure EA, Vandrey RG, Johnson MW, Stitzer ML. Effects of varenicline on abstinence and smoking reward following a programmed lapse. Nicotine Tob Res. 2013 Jan; 15(1):139-48. PMID: 22573730.
      View in: PubMed
    69. Campbell AN, Nunes EV, Miele GM, Matthews A, Polsky D, Ghitza UE, Turrigiano E, Bailey GL, VanVeldhuisen P, Chapdelaine R, Froias A, Stitzer ML, Carroll KM, Winhusen T, Clingerman S, Perez L, McClure E, Goldman B, Crowell AR. Design and methodological considerations of an effectiveness trial of a computer-assisted intervention: an example from the NIDA Clinical Trials Network. Contemp Clin Trials. 2012 Mar; 33(2):386-95. PMID: 22085803.
      View in: PubMed
    70. McClure EA, Stitzer ML, Vandrey R. Characterizing smoking topography of cannabis in heavy users. Psychopharmacology (Berl). 2012 Mar; 220(2):309-18. PMID: 21922170.
      View in: PubMed
    71. McClure EA, Saulsgiver KA, Wynne CD. D-amphetamine, nicotine, and haloperidol produce similar disruptions in spatial and nonspatial temporal discrimination procedures. Behav Pharmacol. 2011 Apr; 22(2):101-12. PMID: 21301325.
      View in: PubMed
    72. McClure EA, Saulsgiver KA, Wynne CD. Disruptive effects of stimulus intensity on two variations of a temporal discrimination procedure. J Exp Anal Behav. 2010 Jul; 94(1):57-68. PMID: 21279162.
      View in: PubMed
    73. McClure EA, Saulsgiver KA, Wynne CD. ABA chronic dosing of D-amphetamine produces differential drug effects in two variants of a temporal discrimination procedure in pigeons. Behav Pharmacol. 2009 Dec; 20(8):705-19. PMID: 19901824.
      View in: PubMed
    74. McClure EA, Saulsgiver KA, Wynne CD. Effects of acute and chronic d-amphetamine on two variations of a temporal discrimination procedure. Behav Pharmacol. 2009 Oct; 20(7):668-72. PMID: 19738462.
      View in: PubMed
    75. McClure EA, Saulsgiver KA, Wynne CD. Manipulating pre-feed, density of reinforcement, and extinction produces disruption in the Location variation of a temporal discrimination task in pigeons. Behav Processes. 2009 Sep; 82(1):85-9. PMID: 19615617.
      View in: PubMed
    76. Saulsgiver KA, McClure EA, Wynne CD. Effects of amphetamine on differential reinforcement of low rates of responding. Behav Pharmacol. 2007 Mar; 18(2):119-33. PMID: 17351419.
      View in: PubMed
    77. Jazbec S, Hardin MG, Schroth E, McClure E, Pine DS, Ernst M. Age-related influence of contingencies on a saccade task. Exp Brain Res. 2006 Oct; 174(4):754-62. PMID: 16733706.
      View in: PubMed
    78. Saulsgiver KA, McClure EA, Wynne CD. Effects of d-amphetamine on the behavior of pigeons exposed to the peak procedure. Behav Processes. 2006 Feb 28; 71(2-3):268-85. PMID: 16413140.
      View in: PubMed
    79. Jazbec S, McClure E, Hardin M, Pine DS, Ernst M. Cognitive control under contingencies in anxious and depressed adolescents: an antisaccade task. Biol Psychiatry. 2005 Oct 15; 58(8):632-9. PMID: 16018983.
      View in: PubMed
    80. McClure EA, Saulsgiver KA, Wynne CD. Effects of D-amphetamine on temporal discrimination in pigeons. Behav Pharmacol. 2005 Jul; 16(4):193-208. PMID: 15961959.
      View in: PubMed
    McClure's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    See all (217) concept(s)
    _
    Co-Authors Expand Description
    See all (33) people
    _
    Similar People Expand Description
    See all (60) people
    _
    Same Department Expand Description
    Search Department